Skip Navigation LinksHome > March 2014 - Volume 33 - Issue 3 > Role of Management Strategies in Reducing Mortality From Inv...
Text sizing:
A
A
A
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0000000000000101
Original Studies

Role of Management Strategies in Reducing Mortality From Invasive Fungal Disease in Children With Cancer or Receiving Hemopoietic Stem Cell Transplant: A Single Center 30-year Experience

Castagnola, Elio MD, PhD*; Bagnasco, Francesca PhD; Amoroso, Loredana MD; Caviglia, Ilaria PhD*; Caruso, Silvia PhD; Faraci, Maura MD§; Calvillo, Michaela MD; Moroni, Cristina MD*; Bandettini, Roberto MD; Cangemi, Giuliana PhD; Magnano, Gian Michele MD**; Buffa, Piero MD††; Moscatelli, Andrea MD‡‡; Haupt, Riccardo MD

Collapse Box

Abstract

Background:

In the last decades, several diagnostic and therapeutic strategies have been implemented for management of invasive fungal diseases (IFD) in patients with cancer or receiving allogeneic hemopoietic stem cell transplant. Few data are available on their impact on mortality in children.

Methods:

All IFD episodes diagnosed at tertiary care center during a 30-year period between 1983 and 2012 were analyzed for 90-day mortality and risk factors. Diagnoses were coded according to international (European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group) criteria. Four treatment eras (1983–1990, 1991–1999, 2000–2005 and 2006–2012) were defined according to availability of diagnostic technologies, new antifungal drugs and use of a diagnostic-driven approach without empiric antifungal therapy.

Results:

A total of 198 IFD were diagnosed in 191 patients; 71.2% were proven/probable infections; 39.9% were caused by yeasts and 31.3% by molds. Within 90 days from IFD diagnosis, 58 (30.4%) patients died for a 28.3% cumulative probability of death. A multivariable analysis showed that the highest risk of death was associated with alternative donor-hemopoietic stem cell transplant [hazard ratio (HR): 3.96] and mold etiology (HR: 1.34). The risk of death significantly decreased across the treatment eras, with almost a 3-fold reduced risk for patients diagnosed during the 2006–2012 period (HR: 0.24). Also if the variable year of diagnosis was considered as continuous, the hazard of death significantly decreased by 5% per year (HR: 0.95).

Conclusions:

New management strategies resulted in a better prognosis of IFD in children with cancer or hemopoietic stem cell transplant. A diagnostic-driven approach was not associated with an increase in mortality.

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.